Carregant...
Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis
BACKGROUND: Reactivation of hepatitis B virus (HBV) replication is a well-recognised complication in patients receiving disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA). Limited data exist on HBV reactivation among patients with RA treated with janus kinase (JAK) inhibit...
Guardat en:
| Publicat a: | RMD Open |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7046961/ https://ncbi.nlm.nih.gov/pubmed/32098857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-001095 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|